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(ad-)dressing chronic wounds
Treating Buruli ulcer in cameroon
The infectious disease Buruli ulcer is rarely 
lethal, but it leaves those who suffer from it 
with debilitating deformations of arms and 
legs. Due to traditional beliefs, affected per-
sons are often becoming outcasts. Buruli ulcer 
occurs in tropical regions, around slow running 
rivers. Highest prevalences have been found in 
Sub-Sahara Africa.   
Buruli ulcer is a disease related to leprosy. 
The mode of transmission is still not studied 
enough. It is though suspected to be transmit-
ted via Microorganism living in slow running 
rivers, which enter the skin. 
The symptoms start often with small nodules. 
The tissue below the visible part of the skin 
slowly dies, eventually leading to open wounds. 
These can spread over arms, legs and the back. 
“I had pain for so many months and no hospital 
could treat it”, says Darlyse a 16-year old girl in 
Cameroon. “Before I came to MSF, I just wan-
ted to die.” 
Buruli ulcer
Healing takes months and can cause deep sca-
rring, retractions, and deformity. Death is a rare 
complication. 
Since 1998, there has been a large increase in the 
disease detection rate. Buruli ulcer is now the 
third most common mycobacterial infection in 
human beings after tuberculosis and leprosy, and 
is the most poorly understood of the three disea-
ses. 
The disease often occurs in localised and remote 
areas where populations have limited access to 
medical care. The median age of Buruli ulcer 
patients is about 15 years; the distribution of 
age-specific detection rates peaks at 10–14 years 
and 75–79 years. Buruli ulcer has been reported 
or suspected in 30 tropical countries worldwide, 
including Australia, but west Africa is the most 
affected region.
The number of cases reported in some countries 
of west Africa is substantial: 5700 between 1989 
and 2003 in Benin; 17 000 between 1978 and 2003 
in Côte d’Ivoire, where prevalence reaches 16% in 
some villages;  in Ghana, a national survey done 
in 1999 detected 5619 cases. At the moment Côte 
d’Ivoire reports 2000 new cases annually, Benin 
and Ghana report 1000 new cases annually. These 
are the most endemic countries at this time.
case detection and diagnosis
Patients come very often at a late stage, when the 
open wound is already developed and too large to 
be easily treated. Patients only come when expe-
riencing pain over a longer period and continous 
treatment by traditional healers did not work. 
Lazar, a fisherman in Cameroon says: “I got the 
disease because someone cursed my land. I went 
to traditional healers for years but they couldn’t 
cure me.”
Treatment
If patients come at a lage stage, treatment can take 
up to a year or even longer. In this period they are 
first treated with Antibiotics. According to the 
WHO, “the use of antibiotics has revolutionized 
treatment and contributed to reducing the need 
for surgery by half.” WHO recommends a combi-
nation of rifampicin and streptomycin for 8 weeks 
for the management of Buruli ulcer. 
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Buruli ulcer, a skin 
disease caused by 
Mycobacterium 
ulcerans, is the 
third most common 
mycobacterial disease
after tuberculosis and 
leprosy and mainly 
affects remote rural 
African communities.
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3During the whole treatment process, the wounds 
need to be managed. Necrotic tissue is removed, 
a modern dressing is applied that supports the self 
healing of the skin through controlled humidity 
and epidermization. 
Surgery in the early stages of infection is curative 
and highly costeffective, since it requires a simple 
excision followed by an immediate closure. Howe-
ver, in the disease’s later stages, wide and trauma-
tising excisions are needed,  followed by skin graf-
ting and accompanied by long hospital stays. 
After surgery, the patients receive extensive phy-
siotherapy to prevent functional disabilities. 
A forgotten disease
Buruli ulcer occurs in remote areas, most often in 
surroundings without medical coverage. There is 
little knowledge, treatment and development of 
new treatment options for this disease. 
Together with HUG and other partners, MSF has 
taken the challenge to treat the affected popula-
tion in Cameroons district Akonolinga, to develop 
new treatment options and to make the needs of 
these people visible. 
clinic in Zona 18:  distributing information on sexual violence
Further readings: The Cotonou declaration 
describes the main measures recommended for 
the coming years.  http://www.who.int/neglected_
diseases/Benin_declaration_2009_eng_ok.pdf
sequellae
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Large skin ulcer  
Médecins Sans Frontières (MSF) runs a 
Buruli ulcer treatment programme in the 
Akonolinga district hospital in Cameroon, 
with an overall staff of about 40. The majo-
rity of patients seek treatment at a very late 
stage, mostly due to stigmatisation, lack of 
knowledge of existing treatment and failure 
to recognise clinical signs of the disease in 
its early stages.  To encourage treatment-
seeking behaviour, MSF has adopted an 
active, decentralised case finding approach. 
Outreach teams run door-to-door scree-
nings for Buruli ulcer throughout the district 
and conduct activities to educate and raise 
awareness about the disease. 
Akonolinga is a rural district with very limi-
ted resources. The district is divided into 12 
‘health sectors’, each with its own health cen-
tre. There is one district hospital in Akono-
linga town. 
The MSF programme opened in 2002 to 
support the Ministry of Health district hos-
pital in providing surgery, skin grafting and 
daily dressings. Initially, the programme 
adopted a passive case detection strategy. In 
2005, MSF started introducing systematic 
antibiotic treatment for Buruli ulcer patients. 
Since 2002, the programme has treated over 
830 patients. 
Prevalence study
In 2007 MSF undertook a joint prevalence 
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study with Epicentre to better understand the 
epidemiology of Buruli ulcer in the Akonolinga 
district and to adapt programme management 
accordingly.  
The study found high prevalence rates of Buruli 
ulcer throughout the district, indicating that the 
disease is a public health problem.  45 out of 
10.000 inhabitants in the district were found to 
be infected with Buruli ulcer.  25 out of 45 suffe-
rers presented with skin ulcers;  the rest is either 
non active or shows sequelae. Higher disease 
prevalence was recorded along the river Nyong 
in the same district. Overall, Buruli ulcer pre-
valence in the district is double the Cameroon 
national tuberculosis prevalence rates. 
Medical Management
MSF follows WHO recommendations on holis-
tic care and interdisciplinary treatment teams 
Prevalence in Akonolinga, 
Cameroon in 2007:
45 / 10 000*
Cameroon tuberculosis 
prevalence 2005 :   
20.6 / 10 000
Cameroun leprosy 
prevalence 2005 :  
0.8 / 10 000
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Prevalence in akonolinga is highest along the river.
Medical management approach with Buruli ulcer 
* Prevalence Study:  
Porten K, Sailor K, 
Comte E, Njikap A, 
Sobry A, Sihom F, 
Meva›a A, Eyangoh S, 
Myatt M, Nackers F, 
Grais RF. Prevalence 
of buruli ulcer in 
Akonolinga health 
district, Cameroon: 
results of a cross 
sectional survey. PLoS 
Negl Trop Dis. 2009 Jun 
23;3(6):e466.
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(outlined in the “White Paper On Wound Care”) as well as WHO 
recommendations on treatment for Buruli ulcer. 
Programme cycle Management
In order to successfully adopt medical management, MSF takes 
care of a series of environmental programme issues: 
 
1 - Ensure early detection 
2 - Ensure social mobilization 
3 - Strengthening capacity of health personnel 
4 - Organise regular supervision of staff 
5 - Promote operational research 
6 - Develop cooperation and inter resp. intra-sectoral collabora-
tion in the context of community-based rehabilitation.
In Akonolinga district, all medical activities to treat Buruli ulcer 
are conducted by a joint team of National MSF-staff and interna-
tional employees.
MSF offers free treatment and provides the infrastructure, equip-
ment, and medication necessary to run the Buruli ulcer treatment 
programme. MSF has also established an independent pharmacy 
in the hospital, and provides laboratory support, organisation of 
surgery and sterilisation, and nutritional support to patients. MSF 
staff participate in scientific meetings. MSF also trains local staff 
and brings foreign specialists (surgeons, anaesthesiologists) for 
short periods to Akonolinga.
Treatment resuls
MSF has treated over 830 patients since the project began in 2002. 
Patients are categorized according to the scale of the wound. 
Generally, larger wounds require more complicated treatment. 
As the graph below indicates, the percentage of treatment defaul-
ters is highest in the group with the largest wounds. 
Zone 7: one of the most violent areas in guatemala, Msf supported clinic nearby
haute ecole de sante
Training project in wound care implementation in 
Cameroon with Geneva based wound specialists. 
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Provides support to operational studies, monitoring 
of MSFs implementation of modern wound care, 
study of the relationship between Buruli Ulcer and 
HIV.  Study of efficacy of antibiotics as a treatment for 
Buruli Ulcer. 
Pasteur institute cameroon
Confirmation of diagnostics. Follow up of antibiotic 
resistance. 
epicentre
Epidemiological analysis of the MSF programme. 
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Over the past twelve years wound dressing pro-
tocols  have been revolutionised, but treatment 
protocols used for Buruli ulcer still date from 
the 1980s.   
Using the new protocols will help to reduce the 
cost and complexity of treatment by reducing the 
need for surgery and simplifying the dressing 
methods.  This should improve accessibility to 
treatment and provide sustainable development 
of treatment activities.    
The existing treatments rely on disinfection 
and drying which result in delayed healing. 
For the patient these practices have significant 
drawbacks. Besides, poor dressings can seriously 
impact a patient’s social life since they can lead 
to very unpleasent odor. 
For three years, MSF, with the help of the senior 
Health School of Geneva and University Hos-
pital of Geneva, has developed an innovative 
approach to its wound care programme in the 
fight against Buruli ulcer in Akonolinga district. 
The aim of this project was to show that modern 
dressing protocols can be adapted to tropical 
settings.
MSF has trained doctors and nurses in Came-
roon to update knowledge on the international 
consensus on healing.  MSF has also worked 
dressing chronic wounds
with Cameroonian colleagues to adapt a sheet 
description of wounds that reflects the characte-
ristics of Buruli ulcer. Colour sheets were desig-
ned to facilitate decision-making on treatment 
methods. 
Treatments were proposed which can be achieved 
with the equipment typically found in a health 
centre in Africa ( for example gauze, povidone-
iodine, tulle gras, Vaseline).
MSF has also introduced a limited range of 
modern dressings. The concepts of wound infec-
tion have been addressed to rationalize the use of 
antiseptics and antibiotics. Attention was drawn 
to the struggle against oedema.
Modern dressings facilitate the work of nurses 
and improve patient comfort. They also require 
fewer dressing changes, and  enable  patient care 
by mobile teams that travel to villages twice a 
week, instead of forcing patients to come to the 
clinic on a daily basis. 
Debridement and granulation are clearly effec-
tive. The results obtained on the phase of epithe-
lialization are within the expected scope.  
MSF’s experience shows that the modern appro-
ach of cicatrisation can be adapted to tropical 
environments. The use of modern dressing faci-
litates organization and access to care. MSF aims 
Modern approach of  
cicatrisation
• Consensus on wound bed preparation 
• 3 stages in the healing process
  – necrotic tissue
  – granulation 
  – epidermization 
• Support the healing process
  – necrotic tissue that need to be 
     removed 
     – granulation facilitated by moisture  
     balance
   – epidermization facilitated by edge 
     care
    – infection control when it is necessary
 
This wound preparation can be done with 
the following dressing materials:
• Non commercial material
  – Honey, clay, herbs
• Classical dressing
  – Iodine, gauze, paraffin gauze, etc. 
• Modern dressing
  – alginate, hydrogel, hydrocellular, coal 
dressing, hydrocolloid, etc.) 
The advantages of modern dressing: easy 
to apply, reduction of pain and only needs 
to be changed once or twice per week 
which improves adherence and patient 
comfort in resource limited settings.  
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to see these experiences replicated in other resource-limited settings.
However, there are three primary obstacles to the replication of this 
modern approach – i) the non-recognition of chronic wounds as a 
public health problem; ii) lack of knowledge of international consen-
sus on wound treatment; iii) lack of suitable and affordable materials.
Modern dressings are not essential to healing but they greatly improve 
its practice. The practice of differential pricing for Africa and the 
use of generics have helped to improve access to antiretrovirals for 
HIV treatment, reconciling the interests of patients and pharmaceuti-
cal companies. This example should be adapted for modern wound 
dressings for which prices are too high and dissemination is currently 
insufficient for developing countries.
The delay in the treatment of wounds and scarring found in developing 
countries is not inevitable. Our experience shows that quality care is 
a realistic goal. Modern dressing practices should be adopted widely. 
Africa must not be deprived of modern dressings.
The cost of modern dressings
One use of modern dressing costs between one and four Euro, depen-
ding on the dressing. For chronic wounds it needs up to 20 dressings 
for treatment. In some severe forms, patients permanently need ten 
dressings per month.   The total sum of a treatment with modern dres-
sings in resource limited settings is far too high to be either paid by the 
patient or integrated in primary health care. 
Therefore, Médecins Sans Frontières urges to significantly lower the 
price of modern dressing to make this treatment available to resource 
limited settings. 
Modern dressing 
Médecins  Sans  Frontières is a private international association 
operating in  more  than  75  countries  with close to 400 aid 
programmes. MSF provides assistance to populations in distress, 
to victims of natural or man-made disasters and to victims  of  
armed  conflict.  The organisation was awarded with the Nobel 
Peace Prize in 1999.  MSF  is  working  in  Cameroon  for more 
than 8  years, providing HIV/Aids-care and responding to 
emergencies. At present, MSF provides medical care for Buruli 
Ulcer.
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